Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Electroconvulsive therapy and later stroke in patients with affective disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Suicidal behaviour among persons with attention-deficit hyperactivity disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Attention-deficit hyperactivity disorder and anxiety disorders as precursors of bipolar disorder onset in adulthood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Detail, dynamics and depth: useful correctives for some current research trends

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Multivitamin use and risk of preeclampsia in a high-income population: A cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Type 1 diabetes in children born after assisted reproductive technology: a register-based national cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ovarian cortical follicle density in infertile women with low anti-Müllerian hormone

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Is cesarean section a cause of affective disorders?-A national cohort study using sibling designs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Enhanced sensitivity to oestrogen signalling may drive increased risk for depressive symptoms when exposed to peripartum sex-steroid hormone fluctuations.AimTesting if 116 pre-identified sex steroid-responsive transcripts that predicted perinatal depression (PND) translates to a pharmacological model of hormone-induced mood changes.

METHOD: We generated longitudinal, genome-wide gene-expression and DNA-methylation data from 60 women exposed to a gonadotrophin-releasing hormone agonist (GnRHa) or placebo. We used linear mixed-effect models to assess differences between baseline and follow-up for gene expression and DNA methylation in the biphasic ovarian response to GnRHa.

RESULTS: Of the 116 PND-predictive transcripts, a significant (19%) overlap was observed with those differentially expressed post-GnRHa at both early and later follow-up, indicating sustained effects. Similarly, 49% of tested genes were differentially methylated post-GnRHa at the late follow-up. Within the GnRHa group, a large proportion of PND genes were significantly associated (gene expression; DNA methylation) with changes in depressive symptoms (28%; 66%), oestradiol levels (49%; 66%) and neocortex serotonin transporter binding (8%; 45%) between baseline and follow-up.

CONCLUSIONS: Our data bridge clinical PND biomarkers with a pharmacological model of sex hormone-induced mood changes and directly relate oestrogen-induced biological changes with depressive symptoms and associated serotonin-signalling changes. Our data highlight that individual variations in molecular sensitivity to oestrogen associate with susceptibility to hormone-induced mood changes and hold promise for candidate biomarkers.Declaration of interestV.G.F. received honorarium for being a speaker for H. Lundbeck A/S. E.B.B. receives research funding from Böhringer Ingelheim to investigate FKBP5 as a potential drug target for depression.

OriginalsprogEngelsk
TidsskriftBritish Journal of Psychiatry
Vol/bind215
Udgave nummer3
Sider (fra-til)519-527
Antal sider9
ISSN0007-1250
DOI
StatusUdgivet - sep. 2019

ID: 55663040